APO Research
Talk to an analyst

APO RESEARCH · REPORT

Daptomycin

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Daptomycin Industry Growth and Trends Forecast to 2032

20 December 2025108 pages

Choose your research edition.

Industry ResearchDaptomycin Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Daptomycin Industry Growth and Trends Forecast to 2032108 pages · $3,450 USDMarket StructureGlobal Daptomycin Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Daptomycin Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Daptomycin Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Daptomycin market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Daptomycin is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Daptomycin include HENGRUI PHARMA, Hisun, Sagent Pharmaceuticals, Xellia, Fresenius Kabi, Huadong Medicine, Pfizer, Mylan and Merck & Co., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Daptomycin market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Daptomycin market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Daptomycin market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Daptomycin.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Daptomycin market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Daptomycin Market by Company

HENGRUI PHARMA

Hisun

Sagent Pharmaceuticals

Xellia

Fresenius Kabi

Huadong Medicine

Pfizer

Mylan

Merck & Co.

Teva

Daptomycin Segment by Type

350 mg Lyophilized Powder

500 mg Lyophilized Powder

Daptomycin Segment by Application

Adult

Pediatric Patients (1 to 17 years of age)

Daptomycin Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Daptomycin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Daptomycin and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Daptomycin.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Daptomycin manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Daptomycin in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of 350 mg Lyophilized Powder Table 2. Major Company of 500 mg Lyophilized Powder Table 3. Global Daptomycin Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Daptomycin Sales by Type (2021-2026) & (W Units) Table 5. Global Daptomycin Sales Market Share in Volume by Type (2021-2026) Table 6. Global Daptomycin Sales by Type (2021-2026) & (US$ Million) Table 7. Global Daptomycin Sales Market Share in Value by Type (2021-2026) Table 8. Global Daptomycin Price by Type (2021-2026) & (US$/Unit) Table 9. Global Daptomycin Sales by Type (2027-2032) & (W Units) Table 10. Global Daptomycin Sales Market Share in Volume by Type (2027-2032) Table 11. Global Daptomycin Sales by Type (2027-2032) & (US$ Million) Table 12. Global Daptomycin Sales Market Share in Value by Type (2027-2032) Table 13. Global Daptomycin Price by Type (2027-2032) & (US$/Unit) Table 14. North America Daptomycin Sales by Type (2021-2026) & (W Units) Table 15. North America Daptomycin Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Daptomycin Sales by Type (2021-2026) & (W Units) Table 17. Europe Daptomycin Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Daptomycin Sales by Type (2021-2026) & (W Units) Table 19. Asia-Pacific Daptomycin Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Daptomycin Sales by Type (2021-2026) & (W Units) Table 21. Latin America Daptomycin Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Daptomycin Sales by Type (2021-2026) & (W Units) Table 23. Middle East and Africa Daptomycin Sales by Type (2021-2026) & (US$ Million) Table 24. Daptomycin Industry Trends Table 25. Daptomycin Industry Drivers Table 26. Daptomycin Industry Opportunities and Challenges Table 27. Daptomycin Industry Restraints Table 28. Global Daptomycin Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Daptomycin Revenue Market Share by Company (2021-2026) Table 30. Global Daptomycin Sales by Company (2021-2026) & (W Units) Table 31. Global Daptomycin Sales Share by Company (2021-2026) Table 32. Global Daptomycin Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Daptomycin Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Daptomycin Major Company Production Sites and Headquarters Table 35. Global Daptomycin Company, Product Type & Application Table 36. Global Daptomycin Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Daptomycin by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Daptomycin Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Daptomycin Sales by Region (2021-2026) & (W Units) Table 41. Global Daptomycin Sales Market Share in Volume by Region (2021-2026) Table 42. Global Daptomycin Sales by Region (2021-2026) & (US$ Million) Table 43. Global Daptomycin Sales Market Share in Value by Region (2021-2026) Table 44. Global Daptomycin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Daptomycin Sales by Region (2027-2032) & (W Units) Table 46. Global Daptomycin Sales Market Share in Volume by Region (2027-2032) Table 47. Global Daptomycin Sales by Region (2027-2032) & (US$ Million) Table 48. Global Daptomycin Sales Market Share in Value by Region (2027-2032) Table 49. Global Daptomycin Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Daptomycin Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Daptomycin Sales by Application (2021-2026) & (W Units) Table 52. Global Daptomycin Sales Market Share in Volume by Application (2021-2026) Table 53. Global Daptomycin Sales by Application (2021-2026) & (US$ Million) Table 54. Global Daptomycin Sales Market Share in Value by Application (2021-2026) Table 55. Global Daptomycin Price by Application (2021-2026) & (US$/Unit) Table 56. Global Daptomycin Sales by Application (2027-2032) & (W Units) Table 57. Global Daptomycin Sales Market Share in Volume by Application (2027-2032) Table 58. Global Daptomycin Sales by Application (2027-2032) & (US$ Million) Table 59. Global Daptomycin Sales Market Share in Value by Application (2027-2032) Table 60. Global Daptomycin Price by Application (2027-2032) & (US$/Unit) Table 61. North America Daptomycin Sales by Application (2021-2026) & (W Units) Table 62. North America Daptomycin Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Daptomycin Sales by Application (2021-2026) & (W Units) Table 64. Europe Daptomycin Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Daptomycin Sales by Application (2021-2026) & (W Units) Table 66. Asia-Pacific Daptomycin Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Daptomycin Sales by Application (2021-2026) & (W Units) Table 68. Latin America Daptomycin Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Daptomycin Sales by Application (2021-2026) & (W Units) Table 70. Middle East and Africa Daptomycin Sales by Application (2021-2026) & (US$ Million) Table 71. HENGRUI PHARMA Company Information Table 72. HENGRUI PHARMA Business Overview Table 73. HENGRUI PHARMA Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. HENGRUI PHARMA Daptomycin Product Portfolio Table 75. HENGRUI PHARMA Recent Development Table 76. Hisun Company Information Table 77. Hisun Business Overview Table 78. Hisun Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Hisun Daptomycin Product Portfolio Table 80. Hisun Recent Development Table 81. Sagent Pharmaceuticals Company Information Table 82. Sagent Pharmaceuticals Business Overview Table 83. Sagent Pharmaceuticals Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. Sagent Pharmaceuticals Daptomycin Product Portfolio Table 85. Sagent Pharmaceuticals Recent Development Table 86. Xellia Company Information Table 87. Xellia Business Overview Table 88. Xellia Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Xellia Daptomycin Product Portfolio Table 90. Xellia Recent Development Table 91. Fresenius Kabi Company Information Table 92. Fresenius Kabi Business Overview Table 93. Fresenius Kabi Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. Fresenius Kabi Daptomycin Product Portfolio Table 95. Fresenius Kabi Recent Development Table 96. Huadong Medicine Company Information Table 97. Huadong Medicine Business Overview Table 98. Huadong Medicine Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Huadong Medicine Daptomycin Product Portfolio Table 100. Huadong Medicine Recent Development Table 101. Pfizer Company Information Table 102. Pfizer Business Overview Table 103. Pfizer Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Pfizer Daptomycin Product Portfolio Table 105. Pfizer Recent Development Table 106. Mylan Company Information Table 107. Mylan Business Overview Table 108. Mylan Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Mylan Daptomycin Product Portfolio Table 110. Mylan Recent Development Table 111. Merck & Co. Company Information Table 112. Merck & Co. Business Overview Table 113. Merck & Co. Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 114. Merck & Co. Daptomycin Product Portfolio Table 115. Merck & Co. Recent Development Table 116. Teva Company Information Table 117. Teva Business Overview Table 118. Teva Daptomycin Sales (W Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 119. Teva Daptomycin Product Portfolio Table 120. Teva Recent Development Table 121. North America Daptomycin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 122. North America Daptomycin Sales by Country (2021-2026) & (W Units) Table 123. North America Daptomycin Sales Market Share by Country (2021-2026) Table 124. North America Daptomycin Sales Forecast by Country (2027-2032) & (W Units) Table 125. North America Daptomycin Sales Market Share Forecast by Country (2027-2032) Table 126. North America Daptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. North America Daptomycin Market Size by Country (2021-2026) & (US$ Million) Table 128. North America Daptomycin Market Share by Country (2021-2026) Table 129. North America Daptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. North America Daptomycin Market Share Forecast by Country (2027-2032) Table 131. Europe Daptomycin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 132. Europe Daptomycin Sales by Country (2021-2026) & (W Units) Table 133. Europe Daptomycin Sales Market Share by Country (2021-2026) Table 134. Europe Daptomycin Sales Forecast by Country (2027-2032) & (W Units) Table 135. Europe Daptomycin Sales Market Share Forecast by Country (2027-2032) Table 136. Europe Daptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Europe Daptomycin Market Size by Country (2021-2026) & (US$ Million) Table 138. Europe Daptomycin Market Share by Country (2021-2026) Table 139. Europe Daptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Europe Daptomycin Market Share Forecast by Country (2027-2032) Table 141. Asia-Pacific Daptomycin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 142. Asia-Pacific Daptomycin Sales by Country (2021-2026) & (W Units) Table 143. Asia-Pacific Daptomycin Sales Market Share by Country (2021-2026) Table 144. Asia-Pacific Daptomycin Sales Forecast by Country (2027-2032) & (W Units) Table 145. Asia-Pacific Daptomycin Sales Market Share Forecast by Country (2027-2032) Table 146. Asia-Pacific Daptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Asia-Pacific Daptomycin Market Size by Country (2021-2026) & (US$ Million) Table 148. Asia-Pacific Daptomycin Market Share by Country (2021-2026) Table 149. Asia-Pacific Daptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Asia-Pacific Daptomycin Market Share Forecast by Country (2027-2032) Table 151. Latin America Daptomycin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 152. Latin America Daptomycin Sales by Country (2021-2026) & (W Units) Table 153. Latin America Daptomycin Sales Market Share by Country (2021-2026) Table 154. Latin America Daptomycin Sales Forecast by Country (2027-2032) & (W Units) Table 155. Latin America Daptomycin Sales Market Share Forecast by Country (2027-2032) Table 156. Latin America Daptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Latin America Daptomycin Market Size by Country (2021-2026) & (US$ Million) Table 158. Latin America Daptomycin Market Share by Country (2021-2026) Table 159. Latin America Daptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Latin America Daptomycin Market Share Forecast by Country (2027-2032) Table 161. Middle East and Africa Daptomycin Market Size Growth Rate (CAGR) by Country (W Units): 2021 VS 2025 VS 2032 Table 162. Middle East and Africa Daptomycin Sales by Country (2021-2026) & (W Units) Table 163. Middle East and Africa Daptomycin Sales Market Share by Country (2021-2026) Table 164. Middle East and Africa Daptomycin Sales Forecast by Country (2027-2032) & (W Units) Table 165. Middle East and Africa Daptomycin Sales Market Share Forecast by Country (2027-2032) Table 166. Middle East and Africa Daptomycin Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 167. Middle East and Africa Daptomycin Market Size by Country (2021-2026) & (US$ Million) Table 168. Middle East and Africa Daptomycin Market Share by Country (2021-2026) Table 169. Middle East and Africa Daptomycin Market Size Forecast by Country (2027-2032) & (US$ Million) Table 170. Middle East and Africa Daptomycin Market Share Forecast by Country (2027-2032) Table 171. Key Raw Materials Table 172. Raw Materials Key Suppliers Table 173. Daptomycin Distributors List Table 174. Daptomycin Customers List Table 175. Research Programs/Design for This Report Table 176. Authors List of This Report Table 177. Secondary Sources Table 178. Primary Sources List of Figures Figure 1. Daptomycin Image Figure 2. Global Daptomycin Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Daptomycin Market Size (2021-2032) & (US$ Million) Figure 4. Global Daptomycin Sales (2021-2032) & (W Units) Figure 5. 350 mg Lyophilized Powder Image Figure 6. Global 350 mg Lyophilized Powder Sales YoY Growth (2021-2032) & (W Units) Figure 7. 500 mg Lyophilized Powder Image Figure 8. Global 500 mg Lyophilized Powder Sales YoY Growth (2021-2032) & (W Units) Figure 9. Global Daptomycin Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Daptomycin Market Share by Type 2025 VS 2032 Figure 11. North America Daptomycin Sales Market Share in Volume by Type in 2025 Figure 12. North America Daptomycin Sales Market Share in Value by Type in 2025 Figure 13. Europe Daptomycin Sales Market Share in Volume by Type in 2025 Figure 14. Europe Daptomycin Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Daptomycin Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Daptomycin Sales Market Share in Value by Type in 2025 Figure 17. Latin America Daptomycin Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Daptomycin Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Daptomycin Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Daptomycin Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Daptomycin Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Adult Image Figure 24. Global Adult Sales YoY Growth (2021-2032) & (W Units) Figure 25. Pediatric Patients (1 to 17 years of age) Image Figure 26. Global Pediatric Patients (1 to 17 years of age) Sales YoY Growth (2021-2032) & (W Units) Figure 27. Global Daptomycin Market Size Overview by Application (2021-2032) & (US$ Million) Figure 28. Global Daptomycin Market Share by Application 2025 VS 2032 Figure 29. North America Daptomycin Sales Market Share in Volume by Application in 2025 Figure 30. North America Daptomycin Sales Market Share in Value by Application in 2025 Figure 31. Europe Daptomycin Sales Market Share in Volume by Application in 2025 Figure 32. Europe Daptomycin Sales Market Share in Value by Application in 2025 Figure 33. Asia-Pacific Daptomycin Sales Market Share in Volume by Application in 2025 Figure 34. Asia-Pacific Daptomycin Sales Market Share in Value by Application in 2025 Figure 35. Latin America Daptomycin Sales Market Share in Volume by Application in 2025 Figure 36. Latin America Daptomycin Sales Market Share in Value by Application in 2025 Figure 37. Middle East and Africa Daptomycin Sales Market Share in Volume by Application in 2025 Figure 38. Middle East and Africa Daptomycin Sales Market Share in Value by Application in 2025 Figure 39. North America Daptomycin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 40. North America Daptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 41. North America Daptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 42. North America Daptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 43. Europe Daptomycin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 44. Europe Daptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Daptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Daptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Asia-Pacific Daptomycin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 48. Asia-Pacific Daptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Daptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Asia-Pacific Daptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Latin America Daptomycin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 52. Latin America Daptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Daptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Latin America Daptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Middle East and Africa Daptomycin Sales by Country: 2021 VS 2025 VS 2032 (W Units) Figure 56. Middle East and Africa Daptomycin Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Daptomycin Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Middle East and Africa Daptomycin Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Daptomycin Value Chain Figure 60. Key Raw Materials Price Figure 61. Manufacturing Cost Structure Figure 62. Daptomycin Production Mode & Process Figure 63. Direct Comparison with Distribution Share Figure 64. Distributors Profiles Figure 65. Years Considered Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • 350 mg Lyophilized Powder
  • 500 mg Lyophilized Powder
Applications
  • Adult
  • Pediatric Patients (1 to 17 years of age)
Companies covered
  • HENGRUI PHARMA
  • Hisun
  • Sagent Pharmaceuticals
  • Xellia
  • Fresenius Kabi
  • Huadong Medicine
  • Pfizer
  • Mylan
  • Merck & Co.
  • Teva

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Daptomycin Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Daptomycin Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Daptomycin Market by Type
  6. 1.3.1 350 mg Lyophilized Powder
  7. 1.3.2 500 mg Lyophilized Powder
  8. 1.4 Global Daptomycin Market Size by Type
  9. 1.4.1 Global Daptomycin Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Daptomycin Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Daptomycin Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Daptomycin Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Daptomycin Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Daptomycin Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Daptomycin Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Daptomycin Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Daptomycin Industry Trends
  2. 2.2 Daptomycin Industry Drivers
  3. 2.3 Daptomycin Industry Opportunities and Challenges
  4. 2.4 Daptomycin Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Daptomycin Revenue (2021-2026)
  2. 3.2 Global Top Players by Daptomycin Sales (2021-2026)
  3. 3.3 Global Top Players by Daptomycin Price (2021-2026)
  4. 3.4 Global Daptomycin Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Daptomycin Major Company Production Sites & Headquarters
  6. 3.6 Global Daptomycin Company, Product Type & Application
  7. 3.7 Global Daptomycin Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Daptomycin Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Daptomycin Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Daptomycin Tier 1, Tier 2, and Tier 3
4 Daptomycin Regional Status and Outlook
  1. 4.1 Global Daptomycin Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Daptomycin Historic Market Size by Region
  3. 4.2.1 Global Daptomycin Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Daptomycin Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Daptomycin Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Daptomycin Forecasted Market Size by Region
  7. 4.3.1 Global Daptomycin Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Daptomycin Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Daptomycin Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Daptomycin by Application
  1. 5.1 Daptomycin Market by Application
  2. 5.1.1 Adult
  3. 5.1.2 Pediatric Patients (1 to 17 years of age)
  4. 5.2 Global Daptomycin Market Size by Application
  5. 5.2.1 Global Daptomycin Market Size Overview by Application (2021-2032)
  6. 5.2.2 Global Daptomycin Historic Market Size Review by Application (2021-2026)
  7. 5.2.3 Global Daptomycin Forecasted Market Size by Application (2027-2032)
  8. 5.3 Key Regions Market Size by Application
  9. 5.3.1 North America Daptomycin Sales Breakdown by Application (2021-2026)
  10. 5.3.2 Europe Daptomycin Sales Breakdown by Application (2021-2026)
  11. 5.3.3 Asia-Pacific Daptomycin Sales Breakdown by Application (2021-2026)
  12. 5.3.4 South America Daptomycin Sales Breakdown by Application (2021-2026)
  13. 5.3.5 Middle East and Africa Daptomycin Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 HENGRUI PHARMA
  2. 6.1.1 HENGRUI PHARMA Company Information
  3. 6.1.2 HENGRUI PHARMA Business Overview
  4. 6.1.3 HENGRUI PHARMA Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 HENGRUI PHARMA Daptomycin Product Portfolio
  6. 6.1.5 HENGRUI PHARMA Recent Developments
  7. 6.2 Hisun
  8. 6.2.1 Hisun Company Information
  9. 6.2.2 Hisun Business Overview
  10. 6.2.3 Hisun Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Hisun Daptomycin Product Portfolio
  12. 6.2.5 Hisun Recent Developments
  13. 6.3 Sagent Pharmaceuticals
  14. 6.3.1 Sagent Pharmaceuticals Company Information
  15. 6.3.2 Sagent Pharmaceuticals Business Overview
  16. 6.3.3 Sagent Pharmaceuticals Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Sagent Pharmaceuticals Daptomycin Product Portfolio
  18. 6.3.5 Sagent Pharmaceuticals Recent Developments
  19. 6.4 Xellia
  20. 6.4.1 Xellia Company Information
  21. 6.4.2 Xellia Business Overview
  22. 6.4.3 Xellia Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Xellia Daptomycin Product Portfolio
  24. 6.4.5 Xellia Recent Developments
  25. 6.5 Fresenius Kabi
  26. 6.5.1 Fresenius Kabi Company Information
  27. 6.5.2 Fresenius Kabi Business Overview
  28. 6.5.3 Fresenius Kabi Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Fresenius Kabi Daptomycin Product Portfolio
  30. 6.5.5 Fresenius Kabi Recent Developments
  31. 6.6 Huadong Medicine
  32. 6.6.1 Huadong Medicine Company Information
  33. 6.6.2 Huadong Medicine Business Overview
  34. 6.6.3 Huadong Medicine Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Huadong Medicine Daptomycin Product Portfolio
  36. 6.6.5 Huadong Medicine Recent Developments
  37. 6.7 Pfizer
  38. 6.7.1 Pfizer Company Information
  39. 6.7.2 Pfizer Business Overview
  40. 6.7.3 Pfizer Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Pfizer Daptomycin Product Portfolio
  42. 6.7.5 Pfizer Recent Developments
  43. 6.8 Mylan
  44. 6.8.1 Mylan Company Information
  45. 6.8.2 Mylan Business Overview
  46. 6.8.3 Mylan Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Mylan Daptomycin Product Portfolio
  48. 6.8.5 Mylan Recent Developments
  49. 6.9 Merck & Co.
  50. 6.9.1 Merck & Co. Company Information
  51. 6.9.2 Merck & Co. Business Overview
  52. 6.9.3 Merck & Co. Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Merck & Co. Daptomycin Product Portfolio
  54. 6.9.5 Merck & Co. Recent Developments
  55. 6.10 Teva
  56. 6.10.1 Teva Company Information
  57. 6.10.2 Teva Business Overview
  58. 6.10.3 Teva Daptomycin Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Teva Daptomycin Product Portfolio
  60. 6.10.5 Teva Recent Developments
7 North America by Country
  1. 7.1 North America Daptomycin Sales by Country
  2. 7.1.1 North America Daptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Daptomycin Sales by Country (2021-2026)
  4. 7.1.3 North America Daptomycin Sales Forecast by Country (2027-2032)
  5. 7.2 North America Daptomycin Market Size by Country
  6. 7.2.1 North America Daptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Daptomycin Market Size by Country (2021-2026)
  8. 7.2.3 North America Daptomycin Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Daptomycin Sales by Country
  2. 8.1.1 Europe Daptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Daptomycin Sales by Country (2021-2026)
  4. 8.1.3 Europe Daptomycin Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Daptomycin Market Size by Country
  6. 8.2.1 Europe Daptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Daptomycin Market Size by Country (2021-2026)
  8. 8.2.3 Europe Daptomycin Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Daptomycin Sales by Country
  2. 9.1.1 Asia-Pacific Daptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Daptomycin Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Daptomycin Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Daptomycin Market Size by Country
  6. 9.2.1 Asia-Pacific Daptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Daptomycin Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Daptomycin Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Daptomycin Sales by Country
  2. 10.1.1 South America Daptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Daptomycin Sales by Country (2021-2026)
  4. 10.1.3 South America Daptomycin Sales Forecast by Country (2027-2032)
  5. 10.2 South America Daptomycin Market Size by Country
  6. 10.2.1 South America Daptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Daptomycin Market Size by Country (2021-2026)
  8. 10.2.3 South America Daptomycin Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Daptomycin Sales by Country
  2. 11.1.1 Middle East and Africa Daptomycin Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Daptomycin Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Daptomycin Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Daptomycin Market Size by Country
  6. 11.2.1 Middle East and Africa Daptomycin Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Daptomycin Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Daptomycin Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Daptomycin Value Chain Analysis
  2. 12.1.1 Daptomycin Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Daptomycin Production Mode & Process
  7. 12.2 Daptomycin Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Daptomycin Distributors
  10. 12.2.3 Daptomycin Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst